Man

Francisco Nicolas Acevedo Claros

Medico Oncologo

Pontificia Universidad Católica de Chile

Santiago, Chile

Líneas de Investigación


Cancer de mama. Dieta y ejercicio. Prevencion de cancer de mama. Marcadores de inflamacion. Desarrollo de base de datos en Cancer de mama

Educación

  •  Medico Oncologo, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2013

Experiencia Académica

  •   Medico Oncologo Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicina

    Chile

    2010 - A la fecha

Experiencia Profesional

  •   Medico Oncologo Full Time

    Pontificia Universidad Catolica

    Chile

    2013 - A la fecha

  •   Post Doctoral Research Fellow Full Time

    Dana Farber Cancer Institue

    Boston, Estados Unidos

    2018 - 2018

  •   Post Doctoral Research Fellow Full Time

    Massachussets General Hospital

    Boston, Chile

    2017 - 2017


 

Article (37)

Complete Response to Immunotherapy Plus Chemotherapy After an Unusual Clinical Response to Afatinib and Stereotactic Radiosurgery in a Patient With Metastatic EGFR-Mutant Non–Small-Cell Lung Cancer
Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
First-line endocrine therapy for advanced breast cancer. A real-world study at a Latin American university health institution
Mammography correlates to better survival rates in breast cancer patients: a 20-year experience in a University health institution
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities
Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?
Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective
High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study
Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties
Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions
The neutrophil to lymphocyte ratio predicts the response to neoadjuvant chemotherapy in luminal B breast cancer
Using Machine Learning and Natural Language Processing to Review and Classify the Medical Literature on Cancer Susceptibility Genes
Aplicación de tres modelos pronósticos en cáncer de mama precoz
Can histological grade and mitotic index replace Ki67 to determine luminal breast cancer subtypes?
Características clínicas y pronóstico de pacientes con cáncer de mama HER2 positivo avanzado, en la era antes y después de terapias anti-HER2
Chilean Gastric Cancer Task Force A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients
Managing Patient with Mutations in PALB2, CHEK2, or ATM
Risk factors for loco-regional recurrence in breast cancer patients: A retrospective study
Central nervous system metastasis secondary to colorectal cancer: a retrospective cohort study of 20 cases
Clinico-pathologic subtypes of breast cancer primary tumors are related to prognosis after recurrence
Evaluación del valor pronóstico de la relación neutrófilos/linfocitos en cáncer de mama de subtipos agresivos
High prevalence of vitamin D deficiency in women with breast cancer: The first Chilean study
[Predictive value of conventional immuno-histochemical biomarkers in breast cancer].
Breast cancer at extreme ages - A comparative analysis in Chile
Predictive value of conventional immunohistochemical biomarkers in breast cancer
Breast cancer and pregnancy: a comparative analysis of a Chilean cohort.
CARACTERÍSTICAS CLÍNICO-PATOLÓGICAS Y SOBREVIDA DE PACIENTES CON CÁNCER DE MAMA BILATERAL SINCRÓNICO
Clinicopathologic subtypes and compromise of lymph nodes in patients with breast cancer
Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor.
Correlation between Ki67 and Histological Grade in Breast Cancer Patients Treated with Preoperative Chemotherapy
Correlation between Ki67 and Histological Grade in Breast Cancer Patients Treated with Preoperative Chemotherapy
How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey
Survival of patients with metastatic breast cancer according to pathological types of tumors
Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia.
Physical Activity and Breast Cancer Prevention
Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature.
Enfermedad periodontal en pacientes con síndrome coronario agudo

ComunicacionBreve (1)

NUEVAS TERAPIAS SISTÉMICAS PARA EL TRATAMIENTO DEL MELANOMA

Proyecto (1)

SUBTIPOS LINFOCITARIOS COMO FACTOR PREDICTOR DE RESPUESTA EN PACIENTES CON CANCER DE MAMA SOMETIDAS A QUIMIOTERAPIA NEOADYUVANTE

Review (2)

Entendiendo las terapias actuales en melanoma metastásico
Terapia endocrina neoadyuvante en cáncer de mama, una alternativa de tratamiento e investigación
32
Francisco Acevedo

Medico Oncologo

Hemato Oncologia

Pontificia Universidad Católica de Chile

Santiago, Chile

19
Cesar Sanchez

Profesor asistente

Hematologia-oncologia

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

santiago, Chile

6
Mauricio Pinto

Investigador

STORM SPA

Santiago, Chile

5
María Villarroel

Médico Anátomo-Patólogo

Anatomía Patológica

Red de Salud UC Christus / Pontificia Universidad Católica de Chile

Santiago, Chile

4
Miguel Cordova

Estudiando de Doctorado

Departamento de Posgrado

Universidad de Chile

Santiago, Chile

4
Bruno Nervi

Associated Professor

Hematology - Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

3
Ignacio Retamal

Docente

Universidad de Los Andes

Santiago, Chile

3
Gareth Owen

Profesor Titular

Fisiologia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
FERNANDO CROVARI

Jefe Departamento

Cirugía Digestiva

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Marcelo Garrido

Director

CENTRO DEL CÁNCER, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
María Maturana

Bioquimico

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Erica Koch

Oncólogo Médico

Red de Salud UC Christus

Santiago, Chile

2
Ricardo Armisen

Associate Professor

Centro de Genética y Genómica

Universidad del Desarrollo

Santiago, Chile

1
ALEJANDRO CORVALAN

Associate Professor

Hematology and Oncology

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Manuel Espinoza

Profesor Asociado

Salud Pública

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Pablo Muñoz

Profesor Asistente

Hematología-Oncología

Pontificia Universidad Católica de Chile

Santiago, Chile

1
María Rodríguez

Profesora Asociada

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

1
Militza Petric

Médico

Cirugía

Complejo Asistencial Dr. Sótero del Rio

Puente Alto, Chile

1
jose valbuena

Associate Professor

Anatomic Pathology

PONTIFICIA UNIVERSIDAD CATOLICA. FACULTAD DE MEDICINA/ESCUELA DE MEDICINA/ DEPARTAMENTO DE ANATOMÍA PATOLÓGICA

santiago, Chile